Companies: 10,795·Total market cap: $144.5T
Refocus Group, Inc.

Refocus Group, Inc.

RFCSOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$25
P/E Ratio
52W High
52W Low
Overview

Refocus Group, Inc. (RFCS) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · RFCS · as of Jun 9, 2026

Key Statistics

EPS (TTM)rfcs eps ttm · rfcs earnings per shareEarnings history
PE Ratio (TTM)rfcs pe ratio ttm · rfcs price to earningsPE Ratio deep dive
Revenue (TTM)rfcs revenue ttm · rfcs annual revenueFull revenue history
Dividend YieldNo Dividenddoes rfcs pay dividends · rfcs dividend yieldDividend history
Shares Outstandingrfcs shares outstanding · rfcs floatShares outstanding history
Next EarningsTBArfcs earnings date · rfcs next earningsEarnings history

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y-99.99%
5Y-100.00%

About Refocus Group, Inc.

CEOJ. Michael Judy
IPO DateMar 7, 2003
Employees4
CountryUS

Refocus Group, Inc. is a medical technology firm dedicated to the research and creation of therapies for various human vision conditions, particularly presbyopia. A key offering is the VisAbility Micr…

what is refocus group, inc. · rfcs stock overview · refocus group, inc. company profile · who is refocus group, inc. ceo · rfcs OTC · refocus group, inc. headquarters · refocus group, inc. business segments

About Stock Overview & Key Data

Refocus Group, Inc. (RFCS) is a Healthcare company in the Medical - Devices industry, listed on OTC since Mar 7, 2003. As of the latest trading session, RFCS stock price is $0.00, with a market capitalization of $25. The stock has returned -99.99% over the past 12 months and +0.00% year-to-date.

Frequently Asked Questions

As of the latest trading session, Refocus Group, Inc. (RFCS) stock price is $0.00. The stock is traded on OTC under the ticker symbol RFCS. The 52-week range is $1.00 – $6.00.

RFCS stock priceRFCS quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice